2m 2m 2m 2m 2m 2m 2m
Voyager Therapeu (VYGR)
NASDAQ
$3.19-$0.005 (-0.16%)
Price as of Sep 11, 2026 7:30 PM EDT- $196.6MMarket Cap
- -23.68%1-Year Change
- BiotechnologyIndustry
Voyager Therapeu (VYGR)
$3.19-$0.005 (-0.16%)
VYGR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.19 | ||
Change | $0.00 (0.00%) | ||
Open | $3.24 | ||
High | $3.28 | ||
Low | $3.15 | ||
Previous Close | $3.19 | ||
Volume | 276,063 | ||
30-Day Average Volume | 431,152 | ||
1-Week Change | -9.12% | ||
1-Month Change | -0.31% | ||
1-Year Change | -23.68% | ||
3-Year Change | -64.16% | ||
5-Year Change | -3.33% | ||
Fundamentals | |||
Shares Outstanding | 61.6M | ||
Total Assets | $197.8M | ||
Market Cap | $196.6M | ||
Enterprise Value | $160.8M | ||
Period: QTR TTM FY | |||
Revenue | $3.2M | ||
Net Income | -$24.5M | ||
Free Cash Flow | -$25.8M | ||
EBIT | -$24.5M | ||
EBITDA | -$23.5M | ||
Net Working Capital | $108.5M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | -1 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue